Literature DB >> 15618677

Transporter-mediated Drug Interactions.

Akira Tsuji1.   

Abstract

Since 1994, researchers have isolated various genes encoding transporter proteins involved in drug uptake into and efflux from tissues that play key roles in the absorption, distribution and secretion of drugs in animals and humans. The pharmacokinetic characteristics of drugs that are substrates for these transporters are expected to be influenced by coadministered drugs that work as inhibitors or enhancers of the transporter function. This review deals with recent progress in molecular and functional research on drug transporters, and then with transporter-mediated drug interactions in absorption and secretion from the intestine, secretion from the kidney and liver, and transport across the blood-brain barrier in humans. Although the participation of the particular transporters in observed drug-drug interactions can be difficult to confirm in humans, this review focuses mainly on pharmacokinetic interactions of clinically important drugs.

Entities:  

Year:  2002        PMID: 15618677     DOI: 10.2133/dmpk.17.253

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  15 in total

1.  Screening of the interaction between xenobiotic transporters and PDZ proteins.

Authors:  Yukio Kato; Kazuhiro Yoshida; Chizuru Watanabe; Yoshimichi Sai; Akira Tsuji
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

Review 2.  Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.

Authors:  Hongjian Zhang; Donghui Cui; Bonnie Wang; Yong-Hae Han; Praveen Balimane; Zheng Yang; Michael Sinz; A David Rodrigues
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestine.

Authors:  Michael B Bolger; Viera Lukacova; Walter S Woltosz
Journal:  AAPS J       Date:  2009-05-12       Impact factor: 4.009

4.  Influence of drugs and nutrients on transporter gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines.

Authors:  Qing Li; Yoshimichi Sai; Yukio Kato; Ikumi Tamai; Akira Tsuji
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

5.  Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.

Authors:  Caroline A Larregieu; Leslie Z Benet
Journal:  AAPS J       Date:  2013-01-24       Impact factor: 4.009

6.  Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.

Authors:  Toshiyuki Takeuchi; Sumie Yoshitomi; Tomoaki Higuchi; Keiko Ikemoto; Shin-ichi Niwa; Takuya Ebihara; Miki Katoh; Tsuyoshi Yokoi; Satoru Asahi
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

7.  Vascular endothelium-selective gene induction by Tie2 promoter/enhancer in the brain and retina of a transgenic rat.

Authors:  Sumio Ohtsuki; Naoko Kamiya; Satoko Hori; Tetsuya Terasaki
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

8.  Drug-Drug Interactions of a Novel κ-Opioid Receptor Agonist, Nalfurafine Hydrochloride, Involving the P-Glycoprotein.

Authors:  Akihiro Ando; Shinichiro Sasago; Yoshihiro Ohzone; Yohei Miyamoto
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

Review 9.  Strategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamily.

Authors:  Cesare Indiveri; Michele Galluccio; Mariafrancesca Scalise; Lorena Pochini
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

10.  Expression of intestinal transporter genes in beagle dogs.

Authors:  Soo-Min Cho; Sung-Won Park; Na-Hyun Kim; Jin-A Park; Hee Yi; Hee-Jung Cho; Ki-Hwan Park; Ingyun Hwang; Ho-Chul Shin
Journal:  Exp Ther Med       Date:  2012-10-30       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.